Bessemer Group’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$746K Sell
7,811
-496
-6% -$47.6K ﹤0.01% 1064
2026
Q1
$861K Sell
8,307
-6,462
-44% -$733K ﹤0.01% 978
2025
Q4
$1.49M Buy
14,769
+8,871
+150% +$963K ﹤0.01% 871
2025
Q3
$727K Buy
5,898
+397
+7% +$49.3K ﹤0.01% 737
2025
Q2
$661K Sell
5,501
-254
-4% -$33.9K ﹤0.01% 740
2025
Q1
$849K Sell
5,755
-50
-0.9% -$7.63K ﹤0.01% 754
2024
Q4
$943K Buy
5,805
+54
+0.9% +$8.83K ﹤0.01% 776
2024
Q3
$937K Sell
5,751
-176
-3% -$26.1K ﹤0.01% 790
2024
Q2
$809K Sell
5,927
-30,608
-84% -$4.25M ﹤0.01% 708
2024
Q1
$5.59M Sell
36,535
-3,228
-8% -$482K 0.01% 374
2023
Q4
$5.67M Buy
39,763
+29,425
+285% +$3.92M 0.01% 358
2023
Q3
$1.35M Sell
10,338
-283
-3% -$43K ﹤0.01% 552
2023
Q2
$1.69M Buy
10,621
+967
+10% +$156K ﹤0.01% 516
2023
Q1
$1.53M Sell
9,654
-349
-3% -$52.3K ﹤0.01% 504
2022
Q4
$1.4M Buy
10,003
+501
+5% +$71.1K ﹤0.01% 515
2022
Q3
$1.22M Sell
9,502
-528
-5% -$76.2K ﹤0.01% 544
2022
Q2
$1.42M Sell
10,030
-754
-7% -$108K ﹤0.01% 510
2022
Q1
$1.5M Buy
10,784
+1,299
+14% +$199K ﹤0.01% 408
2021
Q4
$1.66M Buy
9,485
+360
+4% +$60K ﹤0.01% 374
2021
Q3
$1.51M Buy
9,125
+653
+8% +$112K ﹤0.01% 354
2021
Q2
$1.52M Buy
8,472
+65
+0.8% +$11.9K ﹤0.01% 356
2021
Q1
$1.62M Buy
8,407
+3,248
+63% +$625K ﹤0.01% 345
2020
Q4
$1.04M Sell
5,159
-10,399
-67% -$2.15M ﹤0.01% 392
2020
Q3
$3.27M Sell
15,558
-42,302
-73% -$9.42M 0.01% 274
2020
Q2
$12.7M Buy
57,860
+6,144
+12% +$1.23M 0.04% 229
2020
Q1
$8.96M Sell
51,716
-35,045
-40% -$5.79M 0.04% 244
2019
Q4
$13.3M Sell
86,761
-16,586
-16% -$2.48M 0.04% 242
2019
Q3
$15.7M Sell
103,347
-176,175
-63% -$27.9M 0.06% 206
2019
Q2
$42.8M Sell
279,522
-334,105
-54% -$51M 0.14% 156
2019
Q1
$98.5M Buy
613,627
+55,610
+10% +$8.63M 0.38% 90
2018
Q4
$86M Buy
558,017
+244,782
+78% +$38.1M 0.37% 86
2018
Q3
$47.1M Sell
313,235
-14,092
-4% -$2M 0.18% 122
2018
Q2
$44.3M Sell
327,327
-2,302
-0.7% -$284K 0.17% 122
2018
Q1
$43.9M Buy
329,629
+88,546
+37% +$11.9M 0.17% 128
2017
Q4
$35.9M Sell
241,083
-39,946
-14% -$5.43M 0.14% 135
2017
Q3
$37.1M Sell
281,029
-36,586
-12% -$4.92M 0.15% 131
2017
Q2
$42.3M Sell
317,615
-170,963
-35% -$23.1M 0.17% 121
2017
Q1
$65.9M Buy
488,578
+12,969
+3% +$1.68M 0.27% 107
2016
Q4
$57.1M Buy
475,609
+548
+0.1% +$64.6K 0.26% 119
2016
Q3
$59.5M Buy
475,061
+69,141
+17% +$9.06M 0.3% 117
2016
Q2
$56.2M Buy
405,920
+129,234
+47% +$16.8M 0.31% 118
2016
Q1
$34.9M Buy
276,686
+226,050
+446% +$28.7M 0.2% 127
2015
Q4
$6.42M Buy
50,636
+884
+2% +$110K 0.04% 212
2015
Q3
$5.75M Sell
49,752
-6,992
-12% -$785K 0.03% 220
2015
Q2
$5.9M Sell
56,744
-22,071
-28% -$2.38M 0.03% 232
2015
Q1
$8.7M Sell
78,815
-7,546
-9% -$819K 0.04% 183
2014
Q4
$9M Buy
86,361
+6,068
+8% +$607K 0.05% 190
2014
Q3
$7.71M Buy
80,293
+2,371
+3% +$214K 0.04% 195
2014
Q2
$7.12M Sell
77,922
-1,029
-1% -$92.2K 0.04% 196
2014
Q1
$6.95M Sell
78,951
-68,344
-46% -$6M 0.05% 180
2013
Q4
$13.7M Buy
147,295
+14,320
+11% +$1.29M 0.1% 145
2013
Q3
$10.9M Sell
132,975
-1,555
-1% -$131K 0.09% 149
2013
Q2
$11.2M Buy
+134,530
New +$11.6M 0.1% 133

Other funds holding CLX

Bessemer Group's CLX Position: Q2 2026 in Review

Bessemer Group reduced its Clorox (CLX) stake by 6% in Q2 2026, selling an estimated $47.6K and leaving 7,811 shares worth $746K. The position accounts for ﹤0.01% of the portfolio, ranked #1064.

Bessemer Group first reported a position in CLX in Q2 2013 and has held it in 53 quarters since. The position peaked at $98.5M in Q1 2019. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Bessemer Group held 7,811 shares of Clorox worth $746K as of Q2 2026.
  • Bessemer Group sold 496 Clorox shares in Q2 2026, an estimated $47.6K.
  • Clorox made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #1064 holding.
  • Bessemer Group first reported a position in Clorox in Q2 2013 and has held it in 53 quarters since.
  • Bessemer Group's Clorox position peaked at $98.5M in Q1 2019.
  • 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.